217 related articles for article (PubMed ID: 30426548)
1. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer.
Liu Y; Li Y; Hou R; Shu Z
J Cell Biochem; 2019 Apr; 120(4):5583-5596. PubMed ID: 30426548
[TBL] [Abstract][Full Text] [Related]
2. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
3. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
4. No evidence of Gremlin1-mediated activation of VEGFR2 signaling in endothelial cells.
Dutton LR; O'Neill CL; Medina RJ; Brazil DP
J Biol Chem; 2019 Nov; 294(48):18041-18045. PubMed ID: 31604823
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
[TBL] [Abstract][Full Text] [Related]
6. Gremlin1 Delivered by Mesenchymal Stromal Cells Promoted Epithelial-Mesenchymal Transition in Human Esophageal Squamous Cell Carcinoma.
Hong D; Liu T; Huang W; Liao Y; Wang L; Zhang Z; Chen H; Zhang X; Xiang Q
Cell Physiol Biochem; 2018; 47(5):1785-1799. PubMed ID: 29953975
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer.
Kim SL; Park YR; Lee ST; Kim SW
Int J Oncol; 2017 Dec; 51(6):1809-1820. PubMed ID: 29075793
[TBL] [Abstract][Full Text] [Related]
9. DHA inhibits Gremlin-1-induced epithelial-to-mesenchymal transition via ERK suppression in human breast cancer cells.
Sung NJ; Kim NH; Bae NY; Jo HS; Park SA
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32141512
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
12. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.
Mar AC; Chu CH; Lee HJ; Chien CW; Cheng JJ; Yang SH; Jiang JK; Lee TC
J Biol Chem; 2015 Sep; 290(36):22212-24. PubMed ID: 26209639
[TBL] [Abstract][Full Text] [Related]
14. miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
Zhu D; Sun Y; Zhang D; Dong M; Jiang G; Zhang X; Zhou J
Oncol Rep; 2018 Aug; 40(2):589-598. PubMed ID: 29845255
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
[TBL] [Abstract][Full Text] [Related]
16. TIPE regulates VEGFR2 expression and promotes angiogenesis in colorectal cancer.
Zhong M; Li N; Qiu X; Ye Y; Chen H; Hua J; Yin P; Zhuang G
Int J Biol Sci; 2020; 16(2):272-283. PubMed ID: 31929755
[No Abstract] [Full Text] [Related]
17. Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway.
Wang Z; Humphries B; Xiao H; Jiang Y; Yang C
Toxicol Appl Pharmacol; 2013 Aug; 271(1):20-9. PubMed ID: 23643801
[TBL] [Abstract][Full Text] [Related]
18. Gremlin1 promotes carcinogenesis of glioma in vitro.
Guan Y; Cheng W; Zou C; Wang T; Cao Z
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):244-256. PubMed ID: 27862197
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
